Frederick Munschauer

Nextomics Biosciences (China) — China

Medicine · Health Sciences

34h-index8.1kcitations74works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(45), Peripheral Neuropathies and Disorders(12), Obsessive-Compulsive Spectrum Disorders(11), Systemic Lupus Erythematosus Research(9), Polyomavirus and related diseases(7)

Publications74 total

Plain Language Summary of a Phase 2b Randomized Controlled Trial of Ecopipam and Its 12-Month Open-Label Extension in Children and Adolescents With Tourette Syndrome
Therapeutic Advances in Neurological Disorders·2026Open Access
6.74 Efficacy of Ecopipam on Motor and Phonic Tics in Tourette’s Disorder: Data From a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Journal of the American Academy of Child & Adolescent Psychiatry·2025
Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome
Movement Disorders Clinical Practice·2025· 2 citedOpen Access
Determining Clinically Meaningful Improvement in Children and Adolescents with Tourette Syndrome Receiving Pharmacotherapy
Journal of Child and Adolescent Psychopharmacology·2025· 2 cited
Clinical Profile of Newly Diagnosed Children With Tourette Syndrome: Observational Cohort Study of a Large Electronic Medical Records Database (P11-6.005)
Neurology·2025
High Rates of Discontinuation of D2 Receptor Antagonists as First-Line Treatment of Tourette Syndrome in Children: A Retrospective Database Analysis (P11-6.001)
Neurology·2025
Changes in Metabolic Parameters and Determination of Minimal Clinically Important Difference in YGTSS-TTS Using Data From the Randomized Phase 2b and Open-Label Extension Studies of Ecopipam For Tourette Syndrome (P11-6.002)
Neurology·2025
The Effect of Ecopipam and its Metabolites on Cardiac Repolarization, QTcF (P10-5.014)
Neurology·2025
6.72 An Anchor-Based Method to Establish Clinically Meaningful Changes in YGTSS-TTS Using Data From the Pooled D1AMOND Clinical Studies of Ecopipam, a Selective D1 Receptor Antagonist, in Tourette's Disorder
Journal of the American Academy of Child & Adolescent Psychiatry·2024Open Access
Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results from the Phase IIb (D1AMOND) Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome (S30.009)
Neurology·2024· 1 cited
Safety and Tolerability of Ecopipam in Tourette Syndrome with Psychiatric Comorbidities (P10-3.001)
Neurology·2024
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Neurology·2020· 99 citedOpen Access
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)
BMC Neurology·2016· 16 citedOpen Access
Real-World Assessment of Relapse Rates in Patients with Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a vs Oral Disease-Modifying Drugs (P6.178)
Neurology·2016
Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke
Journal of Stroke and Cerebrovascular Diseases·2015· 16 cited
Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects
Atherosclerosis·2013· 16 cited
Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood
Atherosclerosis·2013· 35 cited
Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis
Journal of Clinical Immunology·2012· 9 cited
Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen
Journal of Stroke and Cerebrovascular Diseases·2011· 8 cited
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis
Multiple Sclerosis Journal·2011· 102 cited
page 1 of 4Next →

Frequent Co-authors

Bianca Weinstock‐Guttman(25), Ralph H. B. Benedict(18), Robert Zivadinov(17), Rohit Bakshi(9), Michael G. Dwyer(8), Zohara Sternberg(8), Murali Ramanathan(7), Nadir Abdelrahman(6), Lawrence Jacobs(5), Neeta Garg(5), Julian L. Ambrus(5), Diane L. Cookfair(4), Richard A. Rudick(4), Roger L. Priore(4), Allison Drake(4), Kailash C. Chadha(4), David Hojnacki(4), Jitendra Sharma(4), Daniel Sternberg(4), Joan Feichter(3)